Alpha Emitters Market by Radionuclide Type (Actinium-225, Americium-241, Astatine-211), Application (Industrial, Medical) - Global Forecast 2024-2030
The Alpha Emitters Market size was estimated at USD 886.95 million in 2023 and expected to reach USD 1,062.44 million in 2024, at a CAGR 20.18% to reach USD 3,211.95 million by 2030.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Alpha Emitters Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Alpha Emitters Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Alpha Emitters Market, highlighting leading vendors and their innovative profiles. These include Actinium Pharmaceuticals, Inc., Alpha Tau Medical Ltd., Bayer AG, Bracco S.p.A., Cardinal Health, Inc., Eckert & Ziegler, Fusion Pharmaceuticals Inc., Ionetix Corporation, Niowave Inc., Orano Group, RadioMedix, Inc., Siemens Healthineers, and Telix Pharmaceuticals Limited.
Market Segmentation & Coverage
This research report categorizes the Alpha Emitters Market to forecast the revenues and analyze trends in each of the following sub-markets:
Radionuclide Type
Actinium-225
Industrial
Bone Metastasis
Americas
Argentina
California
Australia
Denmark
The report offers valuable insights on the following aspects:
- Market Penetration: It presents comprehensive information on the market provided by key players.
- Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
- Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
- Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
- Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
- What is the market size and forecast of the Alpha Emitters Market?
- Which products, segments, applications, and areas should one consider investing in over the forecast period in the Alpha Emitters Market?
- What are the technology trends and regulatory frameworks in the Alpha Emitters Market?
- What is the market share of the leading vendors in the Alpha Emitters Market?
- Which modes and strategic moves are suitable for entering the Alpha Emitters Market?
Note: PDF & Excel + Online Access - 1 Year
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. Alpha Emitters Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Growing number of patients with cardiac and cancer ailments
- 5.1.1.2. Increased awareness of potential benefits of targeted alpha emitter
- 5.1.1.3. Emerging use of alpha emitters in industrial sectors
- 5.1.2. Restraints
- 5.1.2.1. High cost of production of alpha emitters
- 5.1.3. Opportunities
- 5.1.3.1. Emerging new clinical trial activities for cancer treatment
- 5.1.3.2. Ongoing R&D activities for exploring new application areas of alpha emitters
- 5.1.4. Challenges
- 5.1.4.1. Complex handling and safety hazards of alpha emitters
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of High Inflation
- 5.5. Porter’s Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
- 5.6. Value Chain & Critical Path Analysis
- 5.7. Regulatory Framework
- 6. Alpha Emitters Market, by Radionuclide Type
- 6.1. Introduction
- 6.2. Actinium-225
- 6.3. Americium-241
- 6.4. Astatine-211
- 6.5. Plutonium-239
- 6.6. Radium-226
- 6.7. Uranium-238
- 7. Alpha Emitters Market, by Application
- 7.1. Introduction
- 7.2. Industrial
- 7.3. Medical
- 7.4.1. Bone Metastasis
- 7.4.2. Endocrine Tumors
- 7.4.3. Ovarian Cancer
- 7.4.4. Pancreatic Cancer
- 7.4.5. Prostate Cancer
- 8. Americas Alpha Emitters Market
- 8.1. Introduction
- 8.2. Argentina
- 8.3. Brazil
- 8.4. Canada
- 8.5. Mexico
- 8.6. United States
- 9. Asia-Pacific Alpha Emitters Market
- 9.1. Introduction
- 9.2. Australia
- 9.3. China
- 9.4. India
- 9.5. Indonesia
- 9.6. Japan
- 9.7. Malaysia
- 9.8. Philippines
- 9.9. Singapore
- 9.10. South Korea
- 9.11. Taiwan
- 9.12. Thailand
- 9.13. Vietnam
- 10. Europe, Middle East & Africa Alpha Emitters Market
- 10.1. Introduction
- 10.2. Denmark
- 10.3. Egypt
- 10.4. Finland
- 10.5. France
- 10.6. Germany
- 10.7. Israel
- 10.8. Italy
- 10.9. Netherlands
- 10.10. Nigeria
- 10.11. Norway
- 10.12. Poland
- 10.13. Qatar
- 10.14. Russia
- 10.15. Saudi Arabia
- 10.16. South Africa
- 10.17. Spain
- 10.18. Sweden
- 10.19. Switzerland
- 10.20. Turkey
- 10.21. United Arab Emirates
- 10.22. United Kingdom
- 11. Competitive Landscape
- 11.1. FPNV Positioning Matrix
- 11.2. Market Share Analysis, By Key Player
- 11.3. Competitive Scenario Analysis, By Key Player
- 12. Competitive Portfolio
- 12.1. Key Company Profiles
- 12.1.1. Actinium Pharmaceuticals, Inc.
- 12.1.2. Alpha Tau Medical Ltd.
- 12.1.3. Bayer AG
- 12.1.4. Bracco S.p.A.
- 12.1.5. Cardinal Health, Inc.
- 12.1.6. Eckert & Ziegler
- 12.1.7. Fusion Pharmaceuticals Inc.
- 12.1.8. Ionetix Corporation
- 12.1.9. Niowave Inc.
- 12.1.10. Orano Group
- 12.1.11. RadioMedix, Inc.
- 12.1.12. Siemens Healthineers
- 12.1.13. Telix Pharmaceuticals Limited
- 12.2. Key Product Portfolio
- 13. Appendix
- 13.1. Discussion Guide
- 13.2. License & Pricing
- FIGURE 1. ALPHA EMITTERS MARKET RESEARCH PROCESS
- FIGURE 2. ALPHA EMITTERS MARKET SIZE, 2023 VS 2030
- FIGURE 3. ALPHA EMITTERS MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. ALPHA EMITTERS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
- FIGURE 5. ALPHA EMITTERS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. ALPHA EMITTERS MARKET DYNAMICS
- FIGURE 7. ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2023 VS 2030 (%)
- FIGURE 8. ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 9. ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
- FIGURE 10. ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 11. AMERICAS ALPHA EMITTERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 12. AMERICAS ALPHA EMITTERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 13. UNITED STATES ALPHA EMITTERS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 14. UNITED STATES ALPHA EMITTERS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 15. ASIA-PACIFIC ALPHA EMITTERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 16. ASIA-PACIFIC ALPHA EMITTERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ALPHA EMITTERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ALPHA EMITTERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 19. ALPHA EMITTERS MARKET, FPNV POSITIONING MATRIX, 2023
- FIGURE 20. ALPHA EMITTERS MARKET SHARE, BY KEY PLAYER, 2023
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook